Article
Viral kinetic of HCV genotype-4 during pegylated interferon alpha 2a: ribavirin therapy.
Journal of viral hepatitis - 1 Aug 2008
Derbala M F, El Dweik N Z, Al Kaabi S R, Al-Marri A D, Pasic F, Bener A B, Shebl F M, Amer A M, Butt M T, Yakoob R, John A, Al Mohanadi M, Al Khinji M A
Abstract excerpt
Kinetics of hepatitis C virus (HCV) during pegylated interferon (PEG-IFN) and early monitoring of viral decline were recently described to predict treatment outcomes and in turn reduce the course of treatment, adverse effects and cost. However, there is limited (if any) information on the viral dynamics of HCV-4. Our aim is to follow the HCV-RNA kinetics during PEG-IFN alpha 2a and ribavirin therapy and the best...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.